Short Bowel Syndrome
Short bowel syndrome (SBS) is a condition that occurs when the small intestine is too short to absorb enough nutrients from food, often resulting from surgical removal of a portion of the intestine or congenital defects.
Apixaban in Short Bowel Syndrome Patients
We are studying how the blood levels of apixaban differ in patients with short bowel syndrome who require long-term IV nutrition. This research may help improve treatment strategies for these patients.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Who can participate in the clinical trial?
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
- Are you between 18 and 75 years old?
- Do you have any major gastrointestinal diseases like inflammatory bowel disease or celiac disease?
- Are you currently taking blood thinners like Apixaban, Warfarin, or similar medications?
- Have you had any major gastrointestinal surgery in the last 6 months?
- Are you pregnant or breastfeeding?
What similar medicines might you know?
Don't worry if you don't know the medicines tested in the trial. There is a chance you have heard about the similar medicines. Check the list below to see if you are familiar with any of them.
Abatixent
Abidalo
Aboxoma
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
UZ Leuven
gastro-enterology and hepatology
Heverlee, Belgium
Sponsor: UZ Leuven
Last updated: Nov 26, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.